IPO Update: Maravai LifeSciences Proposes Terms For U.S. IPO

About: Maravai LifeSciences Holdings, Inc. (MRVI), Includes: GNNSF, TMO
by: Donovan Jones
This article is exclusive for subscribers.

Maravai LifeSciences has filed to raise $1.275 billion in an IPO.

The firm provides a range of products and services to biopharmaceutical research organizations worldwide.

MRVI is generating strong growth results across all major metrics, has a solid balance sheet and excellent growth prospects, so the IPO is worth considering.

Quick Take

Maravai LifeSciences Holdings (MRVI) has filed to raise $1.275 billion from the sale of its Class A common stock in an IPO, according to an amended registration statement.

The company